Created at Source Raw Value Validated value
March 11, 2022, 3:30 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Experimental group: 18 patients with COVID-19 with positive reverse transcription polymerase chain reaction (RT-PCR) result for SARS-CoV-2 with acute respiratory syndrome resulting in intubation that will undergo fat collection through liposuction and injection of stromal vascular fraction obtained through enzymatic digestion of the fat in the Good Manufacturing Practice (GMP) laboratory and its dilution in 250 milliliters of 0.9% saline solution. Control group: 18 patients with COVID-19 with positive RT-PCR result for SARS-CoV-2 with acute respiratory syndrome in intubation that will not undergo in any additional procedure to standard treatment.;A11.329.830.500; A11.872.590.500;E02.095.147.500.500.625;E04.936.225.687.;E02.095.147;A10.165.114;A11.872", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "11.329.830.500; A11.872.590.500;E02.095.147.500.500.625;E04.936.225.687.;E02.095.147;A10.165.114;A11.872", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 2386, "treatment_name": "Stromal vascular fraction", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]